The lancet oncology
The most recent articles from:
Lancet Oncol.
-
The lancet oncology · Jun 2020
Multicenter StudyPrimary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trial.
Most patients with low-grade upper tract urothelial cancer are treated by radical nephroureterectomy. We aimed to assess the safety and activity of a non-surgical treatment using instillation of UGN-101, a mitomycin-containing reverse thermal gel. ⋯ UroGen Pharma.